What companies are in SPDR S&P biotech ETF?

What companies are in SPDR S&P biotech ETF?

SPDR S&P Biotech ETF

What is the difference between XBI and IBB?

XBI is an equal-weight ETF, whereas IBB is cap weighted. That gives XBI a potential performance advantage when smaller biotech stocks are surging, but it also makes the ETF more volatile than its cap-weighted peer. XBI’s three-year annualized volatility is nearly 800 basis points higher than that of IBB.

Is there a biotech stock index?

The index is a modified capitalization weighted index that includes securities of The NASDAQ Stock Market listed companies that are classified as either biotechnology or pharmaceutical.

Is XBI ETF a Buy?

For someone looking for broad-based exposure, including a large allocation to smaller, not-yet-profitable biotech companies, XBI is one of the best choices. Someone seeking more exposure to established, profitable, lower-risk biotech majors might better pass on XBI.

What is the ETF symbol for biotech?

Biotechnology ETF List

Is IBB a good ETF?

IBB’s top 10 holdings account for about 38.57% of its total assets under management. The ETF has lost about -19.56% so far this year and is down about -16.48% in the last one year (as of 03/07/2022). In the past 52-week period, it has traded between $121.50 and $176.21.

Is biotech part of Nasdaq?

Nasdaq continues to be the home of biotech for 50+ years. In the first half of 2021, IPO activity was led by the biotech-dominated healthcare sector.

Is NBI market cap weighted?

The Index is a modified market capitalization-weighted index. NBI employs a two-stage weight adjustment scheme.